Healio1d
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
C&EN1d
FDA approves drug for neurofibromatosis
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Managed Healthcare Executive1d
FDA Approves Gomekli, First and Only NF1-PN Treatment for Both Children and Adults
Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...
BGR15d
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
Putnam Daily Voice15d
FDA Approves First Non-Opioid Painkiller In 20+ Years: 'A Historic Milestone'
The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing pain signals from reaching the brain. The approval marks the first new ...
Euronews15d
US drug regulator approves first new type of pain pill in more than 20 years
The Food and Drug Administration (FDA) said it approved Vertex Pharmaceuticals' Journavx for short-term pain after surgery or injuries, making it the first new pharmaceutical pain treatment in ...
U.S. News & World Report15d
FDA Approves First New Non-Opioid Pain Pill in Decades
FDA Approves First New Non-Opioid Pain Pill in Decades By India Edwards HealthDay Reporter FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved ...
CNN17d
FDA approves first new type of pain medication in 25 years
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever ... s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.